Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 406 to 420 of 8905 results

  1. Infants and neonates

    All NICE products on infants and neonates. Includes any guidance, advice and quality standards.

  2. Carers

    All NICE products on carers. Includes any guidance and quality standards.

  3. Multiple sclerosis

    All NICE products on multiple sclerosis. Includes any guidance, advice and quality standards.

  4. Parkinson's disease, tremor and dystonia

    All NICE products on parkinson's disease, tremor and dystonia. Includes any guidance, advice and quality standards.

  5. Spasticity

    All NICE products on spasticity. Includes any guidance and advice.

  6. Transient loss of consciousness

    All NICE products on transient loss of consciousness. Includes any guidance and quality standards.

  7. Care homes

    All NICE products on care homes. Includes any guidance and quality standards.

  8. Oesophageal cancer

    All NICE products on oesophageal cancer. Includes any guidance and quality standards.

  9. Ear, nose and throat conditions

    All NICE products on ear, nose and throat conditions. Includes any guidance, advice and quality standards.

  10. Upper gastrointestinal bleeding

    All NICE products on upper gastrointestinal bleeding. Includes any guidance, advice and quality standards.

  11. Bites and stings

    All NICE products on bites and stings. Includes any guidance and quality standards.

  12. Tuberculosis

    All NICE products on tuberculosis. Includes any guidance and quality standards.

  13. Influenza

    All NICE products on influenza. Includes any guidance and quality standards.

  14. Feverish illness

    All NICE products on feverish illness. Includes any guidance and quality standards.

  15. Ovarian cancer (QS18)

    This quality standard covers the identification and management of familial and genetic risk and the recognition and management of ovarian, fallopian tube and primary peritoneal cancer or borderline ovarian cancer in women, trans men and non-binary people aged 18 and over with female reproductive organs (ovaries, fallopian tubes or a uterus). It describes high-quality care in priority areas for improvement.